Has Jasmine Kaur received payments from drug or device companies?

Yes. Drug and device makers reported $6,193 in general payments to Jasmine Kaur across 226 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jasmine Kaur did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jasmine Kaur come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jasmine Kaur

Psychiatry · Wichita, KSNPI 1992113492

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 226 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations.

$6,193in general payments, 2019–2025

Across 226 payments — averaging $27.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sunovion Pharmaceuticals Inc.$1K
AbbVie$1K
Otsuka America Pharmaceutical, Inc.$649
Axsome Therapeutics, Inc.$624
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$418
Johnson & Johnson$396
plus $2K from 12 others

What the payments were for

Food & beverage$6,181100%
Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sunovion Pharmaceuticals Inc.	70	$1,326
AbbVie	46	$1,128
Otsuka America Pharmaceutical, Inc.	14	$649
Axsome Therapeutics, Inc.	11	$624
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	18	$418
Johnson & Johnson	9	$396
Neurocrine Biosciences, Inc.	9	$346
Alkermes, Inc.	10	$328
Vanda Pharmaceuticals Inc.	10	$249
Lundbeck LLC	8	$153
E.r. Squibb & Sons, L.L.C.	2	$150
Supernus Pharmaceuticals, Inc.	5	$108
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$94
Takeda Pharmaceuticals U.S.A., Inc.	3	$61
Indivior Inc.	3	$57
Merck	3	$45
Teva Pharmaceuticals USA, Inc.	3	$43
Adlon Therapeutics L.p.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,193 in reported general payments places this provider in the 85th percentile of 259 psychiatry providers in Kansas.

See all psychiatry providers in Kansas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	12	$236
Lorazepam	22	$71

Paid to pharmacies, not to this prescriber.

Other psychiatry in Wichita

Sheldon PreskornWichita$498K
Heidi OgdenWichita$55K
Ralph BharatiWichita$26K
Paul MurphyWichita$19K
Dwight St ClairWichita$18K
Mukhtar ShahWichita$12K
Rex LearWichita$11K
Lin XuWichita$9K
Mercedes PeralesWichita$8K
Peter SeilerWichita$6K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →